adMare Industry Builder Series Featuring Dr. Pat Walters: Artificial Intelligence in Drug Discovery – Revolution, Evolution, or Complete Nonsense

On January 22nd, Dr. Pat Walters will join the adMare Industry Builder series to discuss artificial intelligence in drug discovery.  

Many have claimed that Artificial Intelligence (AI) will bring about a revolution in drug discovery and development, while others have argued that we are reaching the zenith of a hype cycle that will lead to a period of disillusionment. As is often the case, the truth lies somewhere between these extremes. Dr. Walters will discuss areas where AI is having a real impact on drug discovery and highlight factors that are necessary to increase its utility. 

This event offers a hybrid experience. You can participate either virtually through Zoom or in person at the Montreal Innovation Centre in the Philippe Walker Auditorium. No registration is required if you're attending in person. If you prefer the virtual option, please use this link to connect to the event: https://zoom.us/j/98163971423

About Dr. Walters 

Pat Walters is Chief Data Officer at Relay Therapeutics in Cambridge, MA.   Prior to joining Relay, he spent more than 20 years at Vertex Pharmaceuticals where he was Global Head of Modeling & Informatics.  Pat is the 2023 recipient of the Herman Skolnik Award for Chemical Information Science from the American Chemical Society.  He is a member of the editorial advisory boards for the Journal of Chemical Information and Modeling and Artificial Intelligence in the Life Sciences, and previously held a similar role with the Journal of Medicinal Chemistry.  Pat is co-author of the book “Deep Learning for the Life Sciences,” published in 2019 by O’Reilly and Associates. He received his Ph.D. in Organic Chemistry from the University of Arizona where he studied the application of artificial intelligence in conformational analysis.